Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997

(Singapore)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	% of complete FU at 5 years		5-year absolute survival %		5-year relative survival %
Site	ICD-10	88-92	93-97	88-92	93-97	888-92	93-97
C01-02	Tongue			35.9	34.0	39.8	39.0
C03-06	Oral cavity			37.7	34.5	43.1	40.6
C07-08	Salivary gland			67.6	65.0	71.9	69.2
C09	Tonsil			21.2	36.1	24.2	39.2
C11	Nasopharynx			50.5	56.7	52.8	59.5
C12-13	Hypopharynx			15.0	8.7	17.7	10.6
C15	Oesophagus			3.3	5.3	4.0	6.2
C16	Stomach			16.6	19.4	19.8	23.3
C18	Colon			41.1	41.8	48.8	50.2
C19-20	Rectum			37.0	42.7	43.4	50.4
C22	Liver			2.3	4.4	2.7	5.1
C23-24	Gall bladder			12.1	11.9	14.5	14.0
C25	Pancreas			5.6	3.4	6.4	4.0
C30-31	Nose/Sinuses			34.7	40.8	37.1	45.9
C32	Larynx			40.0	47.3	47.1	57.1
C33-34	Lung			5.3	6.0	6.2	7.2
C40-41	Bone			52.9	37.2	54.5	38.5
C44	Other skin			76.1	75.2	93.7	95.8
C47+C49	Connective tissue			47.8	51.2	51.3	55.1
C50	Breast			66.3	72.1	70.1	76.2
C53	Cervix			61.2	59.9	64.6	63.5
C54	Corpus uteri			71.3	76.4	74.7	80.6
C56	Ovary			63.4	61.2	66.1	63.7
C61	Prostate			37.3	44.6	52.3	63.0
C62	Testis			83.0	85.1	84.6	86.7
C64	Kidney			38.1	45.3	42.7	50.7
C67	Urinary bladder			48.4	51.8	60.6	64.0
C70-72	Brain & nervous system			22.5	30.2	23.3	30.9
C73	Thyroid			83.5	86.3	86.8	90.3
C81	Hodgkin lymphoma			52.7	69.6	55.0	71.9
C82-85+C96	Non-Hodgkin lymphoma			35.5	42.5	38.6	47.1
C90	Multiple myeloma			16.3	17.2	18.9	19.4
C91	Lymphoid leukaemia			15.6	44.8	16.6	45.9
C92-94	Myeloid leukaemia			15.0	16.7	15.8	17.7

Graphs:

5-year absolute survival comparison

5-year relative survival comparison

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b:	Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)